CN106631793A - 一种二苯并环庚烷衍生物的制备方法 - Google Patents
一种二苯并环庚烷衍生物的制备方法 Download PDFInfo
- Publication number
- CN106631793A CN106631793A CN201610911768.3A CN201610911768A CN106631793A CN 106631793 A CN106631793 A CN 106631793A CN 201610911768 A CN201610911768 A CN 201610911768A CN 106631793 A CN106631793 A CN 106631793A
- Authority
- CN
- China
- Prior art keywords
- dibenzo
- cycloheptane
- preparation
- alkali
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007654 dibenzocycloheptanes Chemical class 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052802 copper Inorganic materials 0.000 claims abstract description 9
- 239000010949 copper Substances 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 7
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- 238000004440 column chromatography Methods 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 4
- -1 biphenyl acetylene compound Chemical class 0.000 claims description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 claims description 4
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- PNGLEYLFMHGIQO-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonate;dihydrate Chemical compound O.O.[Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 PNGLEYLFMHGIQO-UHFFFAOYSA-M 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- JFLVETNCJMPOLY-UHFFFAOYSA-N acetylene 1,1'-biphenyl Chemical group C#C.C1=CC=CC=C1C1=CC=CC=C1 JFLVETNCJMPOLY-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 230000000171 quenching effect Effects 0.000 abstract description 2
- 125000000582 cycloheptyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 44
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- 150000001345 alkine derivatives Chemical class 0.000 description 9
- 235000010290 biphenyl Nutrition 0.000 description 9
- 239000004305 biphenyl Substances 0.000 description 9
- 238000011017 operating method Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229960001338 colchicine Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000004243 Tubulin Human genes 0.000 description 3
- 108090000704 Tubulin Proteins 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004293 19F NMR spectroscopy Methods 0.000 description 2
- BKBBHXQBVJMMHW-UHFFFAOYSA-N 6,7-dihydro-5h-dibenzo[2,1-b:2',1'-e][7]annulene Chemical compound C1CCC2=CC=CC=C2C2=CC=CC=C21 BKBBHXQBVJMMHW-UHFFFAOYSA-N 0.000 description 2
- 208000035126 Facies Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FGOSNANIQLJNSZ-UHFFFAOYSA-N acetonitrile copper Chemical compound [Cu].CC#N.CC#N.CC#N.CC#N FGOSNANIQLJNSZ-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- JRXXLCKWQFKACW-UHFFFAOYSA-N biphenylacetylene Chemical group C1=CC=CC=C1C#CC1=CC=CC=C1 JRXXLCKWQFKACW-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- NMKUAEKKJQYLHK-UHFFFAOYSA-N Allocolchicine Natural products CC(=O)NC1CCC2=CC(OC)=C(OC)C(OC)=C2C2=CC=C(C(=O)OC)C=C21 NMKUAEKKJQYLHK-UHFFFAOYSA-N 0.000 description 1
- 241000255579 Ceratitis capitata Species 0.000 description 1
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 description 1
- 229910015221 MoCl5 Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910003074 TiCl4 Inorganic materials 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- NMKUAEKKJQYLHK-KRWDZBQOSA-N methyl (7s)-7-acetamido-1,2,3-trimethoxy-6,7-dihydro-5h-dibenzo[5,3-b:1',2'-e][7]annulene-9-carboxylate Chemical compound CC(=O)N[C@H]1CCC2=CC(OC)=C(OC)C(OC)=C2C2=CC=C(C(=O)OC)C=C21 NMKUAEKKJQYLHK-KRWDZBQOSA-N 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- GICWIDZXWJGTCI-UHFFFAOYSA-I molybdenum pentachloride Chemical compound Cl[Mo](Cl)(Cl)(Cl)Cl GICWIDZXWJGTCI-UHFFFAOYSA-I 0.000 description 1
- WJJZQSCOTJYYSP-INIZCTEOSA-N n-[(7s)-9-hydroxy-1,2,3-trimethoxy-6,7-dihydro-5h-dibenzo[5,3-b:1',2'-e][7]annulen-7-yl]acetamide Chemical compound C1C[C@H](NC(C)=O)C2=CC(O)=CC=C2C2=C1C=C(OC)C(OC)=C2OC WJJZQSCOTJYYSP-INIZCTEOSA-N 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种二苯并环庚烷衍生物的制备方法,将铜催化剂、碱和配体溶解在有机溶剂中,加入联苯乙炔类化合物和α‑溴代烯丙基丙二酸二乙酯形成反应体系,体系在110℃下反应12小时后,经淬灭、萃取、洗涤、干燥和柱层析处理得到二苯并环庚烷衍生物;该方法扩大了多环稠合环庚烷类化合物的多样性,反应收率良好,具有较大的理论创新价值以及实施价值。
Description
技术领域
本发明属于有机合成领域,具体涉及一种二苯并环庚烷衍生物及其制备方法。
背景技术
秋水仙碱(colchicine)能够与微管蛋白二聚体结合,阻止微管蛋白转换,使细胞停止于有丝分裂中期,从而导致细胞死亡,因此,可以用于地中海热综合征、急性通风等疾病的治疗;而且,它具有很好的抗肿瘤活性,在化疗中具有良好的效果,但是,临床研究表明,秋水仙碱具有较大的毒性不能高剂量的使用。幸运的是,二苯并环庚烷衍生物,包括别秋水仙碱(allocolchicine)、N-acetylcolchinol等许多具有生理活性的药物分子或天然产物,则表现出了比秋水仙碱更强的微管蛋白结合活性和更小的毒副作用(S.Larsson andN.Curr.Top.Med.Chem.,2014,14,274),是一种更有前景的抗肿瘤候选药物之一,因此,二苯并环庚烷衍生物的合成非常重要。
近几年来,二苯并环庚烷的合成研究愈来愈多,比较典型的方法是利用过渡金属MoCl5/TiCl4、Tl(OCOCF3)3、Pb(OAc)4或PhI(OCOCF3)2催化1,3-二芳基丙烷或1,3-二芳基丙烯氧化二芳基偶联反应合成:
但是,上述反应所用的试剂往往具有较强的毒性或者过量的使用强氧化剂,导致难以用于药物分子的合成或者造成反应的适用范围不够理想。其他的一些合成途径则往往需要较多的反应步骤,导致总产率偏低,合成成本较高。鉴于二苯并环庚烷衍生物的优良药用价值,发展简单、高效的二苯并环庚烷合成路线,开发新的抗癌活性药物分子迫在眉睫。
发明内容
本发明要解决的技术问题是提供了一种反应收率良好,绿色环保且具有良好适用范围的二苯并环庚烷衍生物制备方法。
为解决该技术问题,本发明采用的技术方案为:
一种二苯并环庚烷衍生物的制备方法,其特征在于包括如下步骤:
将铜催化剂、碱和配体溶解在有机溶剂中,加入结构式Ⅱ所示的联苯乙炔类化合物和结构式Ⅲ所示α-溴代烯丙基丙二酸二乙酯形成反应体系,体系在110℃下反应12小时后,经淬灭、萃取、洗涤、干燥和柱层析处理得到结构式I所示的二苯并环庚烷衍生物;
其中,R1为氢、甲基、甲氧基、氟、氯、乙酰基、甲酸甲酯基、三氟甲基、苯基或苯乙炔基。
所述的铜催化剂、碱、配体、结构式Ⅱ所示化合物和结构式Ⅲ所示化合物的摩尔比为0.1:2:0.2:1:1.2。
所述的铜催化剂为六氟磷酸四乙腈铜,所述的碱为碳酸钠,所述的配体为联吡啶,所述有机溶剂为甲苯。
所述的萃取可采用乙酸乙酯作为萃取剂。
所述的洗涤可采用饱和食盐水洗。
所述的柱层析分离的条件为:硅胶300-400目,洗脱液:石油醚/乙酸乙酯的体积比为10/1。
同现有技术相比,本发明具有如下优点:1、首次采用铜催化完成α-溴代烯丙基丙二酸二乙酯与联苯乙炔的环化反应;2、实现了一系列二苯并环庚烷衍生物的合成,底物适用范围广,官能团兼容性好;3、反应操作简单,绿色环保,具有良好应用前景。故本发明具有较大的理论创新价值以及实施价值。
具体实施方式
实施例1
取一支干燥的反应管,称入六氟磷酸四乙腈铜(9.0mg,0.025mmol)、碳酸钠(53.0mg,0.5mmol)、联吡啶(7.8mg,0.05mmol),然后加入溶于5mL甲苯的联苯乙炔1a(44.5mg,0.25mmol)和α-溴代烯丙基丙二酸二乙酯2a(83.4mg,0.3mmol)。体系在110℃下反应12h后,加10mL水淬灭,用乙酸乙酯(10mL)萃取三次,合并后用饱和食用水洗涤有机相,无水硫酸钠干燥。有机相浓缩后用硅胶(300-400目)柱层析分离(洗脱液:石油醚/乙酸乙酯的体积比为10/1)得到77mg白色固体3aa,熔点86–88℃,收率82%。产物核磁分析1H NMR(600MHz,CDCl3):δ7.46–7.40(m,2H),7.34–7.28(m,4H),7.25–7.21(m,1H),7.18–7.14(m,1H),5.67–5.64(m,1H),4.24–4.17(m,2H),4.09–4.02(m,2H),3.81–3.74(m,1H),3.04–2.98(m,1H),2.75–2.71(m,1H),2.53–2.48(m,1H),2.13–2.07(m,1H),1.27(t,J=7.1Hz,3H),1.12(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.9,170.5,151.3,140.9,139.7,136.1,135.9,130.3,130.0,128.6,128.5,127.4,127.2,127.0,127.0,125.5,65.3,61.4,61.2,53.9,37.4,35.2,14.0,13.8;HRMS(ESI)calcd for C24H25O4(M+H)+377.1753,found377.1745.
反应式如下:
实施例2
除用结构式1b所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:65%,无色液体。1H NMR(600MHz,CDCl3):δ7.44–7.39(m,2H),7.32–7.26(m,2H),7.21–7.18(m,1H),7.12–7.09(m,1H),6.99–6.96(m,1H),5.68–5.63(m,1H),4.24–4.18(m,2H),4.12–4.04(m,2H),3.79–3.73(m,1H),3.02–2.97(m,1H),2.74–2.70(m,1H),2.49–2.45(m,1H),2.35(s,3H),2.14–2.08(m,1H),1.27(t,J=7.1Hz,3H),1.14(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ171.0,170.6,151.5,139.7,138.0,136.9,136.0,135.9,131.1,129.9,128.6,128.5,127.7,127.1,127.0,125.3,65.3,61.5,61.2,53.7,37.5,35.2,21.1,14.1,13.9;HRMS(ESI)calcd for C25H27O4(M+H)+391.1909,found 391.1905.
反应式如下:
实施例3
除用结构式1c所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:73%,白色固体,熔点为102–104℃。1H NMR(600MHz,CDCl3):δ7.41–7.38(m,2H),7.30–7.26(m,2H),7.24–7.20(m,1H),6.85–6.81(m,1H),6.74–6.71(m,1H),5.67–5.65(m,1H),4.24–4.18(m,2H),4.12–4.05(m,2H),3.82(s,3H),3.78–3.74(m,1H),3.03–2.98(m,1H),2.76–2.71(m,1H),2.50–2.45(m,1H),2.13–2.07(m,1H),1.27(t,J=7.1Hz,3H),1.15(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.9,170.5,158.6,151.4,139.4,137.6,135.7,133.5,131.1,128.5,128.4,127.0,126.9,125.2,116.1,111.7,65.2,61.4,61.2,55.2,53.5,37.6,35.4,14.0,13.8;HRMS(ESI)calcd forC25H27O5(M+H)+407.1858,found 407.1850.
反应式如下:
实施例4
除用结构式1d所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:71%,无色液体。1H NMR(600MHz,CDCl3):δ7.44–7.39(m,2H),7.34–7.31(m,1H),7.29–7.26(m,2H),7.01–6.97(m,1H),6.92–6.89(m,1H),5.68–5.65(m,1H),4.25–4.18(m,2H),4.13–4.06(m,2H),3.81–3.73(m,1H),3.02–2.97(m,1H),2.77–2.73(m,1H),2.52–2.46(m,1H),2.10–2.04(m,1H),1.27(t,J=7.1Hz,3H),1.15(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.8,170.4,161.2(d,J=246.7Hz),150.9,138.8,138.4(d,J=7.6Hz),137.0(d,J=3.1Hz),135.8,131.5(d,J=8.2Hz),128.6,128.6,127.5,127.1,125.7,117.0(d,J=21.1Hz),113.7(d,J=20.9Hz),65.3,61.5,61.3,53.6,37.4,35.2,14.1,13.9;19F NMR(565MHz,CDCl3):δ-115.9;HRMS(ESI)calcd forC24H24O4F(M+H)+395.1659,found 395.1649.
反应式如下:
实施例5
除用结构式1e所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:73%,白色固体,熔点为100–102℃。1H NMR(600MHz,CDCl3):δ7.45–7.39(m,2H),7.36–7.33(m,1H),7.29–7.27(m,2H),7.24–7.21(m,1H),7.19–7.15(m,1H),5.70–5.65(m,1H),4.26–4.18(m,2H),4.15–4.05(m,2H),3.83–3.76(m,1H),3.01–2.95(m,1H),2.79–2.74(m,1H),2.51–2.46(m,1H),2.09–2.03(m,1H),1.27(t,J=7.1Hz,3H),1.16(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.7,170.3,150.7,139.4,138.5,138.0,135.8,132.7,131.2,130.0,128.6,128.5,127.7,127.1,127.0,125.8,65.2,61.5,61.3,53.6,37.3,35.0,14.0,13.8;HRMS(ESI)calcd for C24H24O4Cl(M+H)+411.1363,found 411.1358.
反应式如下:
实施例6
除用结构式1f所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:70%,白色固体,熔点为111–113℃。1H NMR(600MHz,CDCl3):δ7.92–7.86(m,1H),7.81–7.72(m,1H),7.49–7.44(m,2H),7.41–7.37(m,2H),7.32–7.29(m,1H),5.71–5.67(m,1H),4.26–4.20(m,2H),4.13–4.01(m,2H),3.88–3.77(m,1H),3.07–3.00(m,1H),2.79–2.72(m,1H),2.63(s,3H),2.63–2.59(m,1H),2.10–2.03(m,1H),1.27(t,J=7.1Hz,3H),1.13(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ198.0,170.7,170.3,150.6,146.1,138.6,136.7,136.0,135.7,130.3,129.9,128.8,128.7,128.3,127.4,127.2,126.2,65.2,61.5,61.3,53.7,37.4,35.2,26.7,14.1,13.9;HRMS(ESI)calcdfor C26H27O5(M+H)+419.1858,found 419.1844.
反应式如下:
实施例7
除用结构式1g所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:70%,白色固体,熔点为96–98℃。1H NMR(600MHz,CDCl3):δ7.99–7.95(m,1H),7.86–7.84(m,1H),7.47–7.44(m,2H),7.38–7.36(m,2H),7.31–7.29(m,1H),5.69–5.67(m,1H),4.24–4.19(m,2H),4.10–4.02(m,2H),3.93(s,3H),3.83–3.79(m,1H),3.05–3.01(m,1H),2.77–2.73(m,1H),2.62–2.59(m,1H),2.05–2.10(m,1H),1.27(t,J=7.1Hz,3H),1.13(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.7,170.4,167.0,150.7,145.8,138.6,136.4,136.0,131.3,130.1,128.8,128.7,128.6,128.3,128.2,127.2,126.1,65.2,61.5,61.3,53.7,52.1,37.3,35.1,14.0,13.8;HRMS(ESI)calcdfor C26H27O6(M+H)+435.1808,found 435.1804.
反应式如下:
实施例8
除用结构式1h所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:76%,无色液体。1H NMR(600MHz,CDCl3):δ7.57–7.54(m,1H),7.47–7.44(m,2H),7.43–7.37(m,3H),7.32–7.30(m,1H),5.72–5.65(m,1H),4.26–4.18(m,2H),4.11–4.03(m,2H),3.85–3.79(m,1H),3.06–3.02(m,1H),2.82–2.77(m,1H),2.61–2.57(m,1H),2.07–2.01(m,1H),1.28(t,J=7.1Hz,3H),1.11(t,J=7.1Hz,3H);13CNMR(151MHz,CDCl3):δ170.7,170.3,150.3,144.7,138.3,137.1,136.0,130.3,129.1(q,J=32.3Hz),128.8,128.7,128.3,127.2,126.8(q,J=4.0Hz),126.2,124.1(q,J=272.2Hz),123.9(q,J=4.2Hz),65.3,61.6,61.3,53.7,37.3,35.2,14.0,13.8;19F NMR(565MHz,CDCl3):δ-62.2;HRMS(ESI)calcd for C25H24O4F3(M+H)+445.1627,found445.1624.
反应式如下:
实施例9
除用结构式1i所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:77%,白色固体,熔点为153–155℃。1H NMR(600MHz,CDCl3):δ7.66–7.60(m,2H),7.56–7.52(m,1H),7.51–7.47(m,1H),7.47–7.42(m,3H),7.42–7.32(m,4H),7.32–7.28(m,1H),5.72–5.65(m,1H),4.27–4.17(m,2H),4.10–4.00(m,2H),3.85–3.78(m,1H),3.11–3.02(m,1H),2.79–2.73(m,1H),2.65–2.55(m,1H),2.17–2.10(m,1H),1.27(t,J=7.1Hz,3H),1.10(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.9,170.5,151.2,140.7,140.0,140.0,139.3,136.6,136.0,130.5,128.9,128.7,128.7,128.6,127.5,127.3,127.1,127.1,125.7,125.6,65.3,61.5,61.2,53.8,37.5,35.5,14.1,13.8;HRMS(ESI)calcd for C30H29O4(M+H)+453.2066,found 453.2062.
反应式如下:
实施例10
除用结构式1j所示的联苯乙炔类化合物代替实施事例1中结构式1a所示的联苯乙炔外,其余操作步骤同实施例1,产率:52%,白色固体,熔点为152–154℃。1H NMR(600MHz,CDCl3):δ7.56–7.54(m,2H),7.48–7.43(m,3H),7.37–7.34(m,5H),7.30–7.28(m,2H),5.70–5.67(m,1H),4.24–4.18(m,2H),4.12–4.04(m,2H),3.83–3.78(m,1H),3.03–2.98(m,1H),2.80–2.73(m,1H),2.56–2.51(m,1H),2.14–2.07(m,1H),1.27(t,J=7.1Hz,3H),1.15(t,J=7.1Hz,3H);13C NMR(151MHz,CDCl3):δ170.8,170.5,150.9,141.2,139.0,136.4,136.0,133.3,131.6,130.3,130.1,128.7,128.6,128.3,128.2,127.8,127.1,125.9,123.3,122.0,89.7,89.4,65.3,61.5,61.3,53.7,37.5,35.1,14.1,13.9;HRMS(ESI)calcd forC32H29O4(M+H)+477.2066,found 477.2043.
反应式如下:
Claims (3)
1.一种二苯并环庚烷衍生物的制备方法,其特征在于包括如下步骤:
将铜催化剂、碱和配体溶解在有机溶剂中,加入结构式Ⅱ所示的联苯乙炔类化合物和结构式Ⅲ所示α-溴代烯丙基丙二酸二乙酯形成反应体系,体系在110℃下反应12小时后,经淬灭、萃取、洗涤、干燥和柱层析处理得到结构式I所示的二苯并环庚烷衍生物;
其中R1为氢、甲基、甲氧基、氟、氯、乙酰基、甲酸甲酯基、三氟甲基、苯基或苯乙炔基。
2.根据权利要求1所述的制备方法,其特征在于,所述的铜催化剂、碱、配体、结构式Ⅱ所示化合物和结构式Ⅲ所示化合物的摩尔比为0.1:2:0.2:1:1.2。
3.根据权利要求1所述的制备方法,其特征在于,所述的铜催化剂为六氟磷酸四乙腈铜,碱为碳酸钠,配体为联吡啶,有机溶剂为甲苯。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610911768.3A CN106631793B (zh) | 2016-10-19 | 2016-10-19 | 一种二苯并环庚烷衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610911768.3A CN106631793B (zh) | 2016-10-19 | 2016-10-19 | 一种二苯并环庚烷衍生物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106631793A true CN106631793A (zh) | 2017-05-10 |
CN106631793B CN106631793B (zh) | 2019-03-08 |
Family
ID=58855622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610911768.3A Active CN106631793B (zh) | 2016-10-19 | 2016-10-19 | 一种二苯并环庚烷衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106631793B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1609086A (zh) * | 2003-04-14 | 2005-04-27 | 弗·哈夫曼-拉罗切有限公司 | Mptp亲和标记物 |
CN101223153A (zh) * | 2005-05-12 | 2008-07-16 | 默克勒有限公司 | 二苯并环庚烷化合物和含有这些化合物的药物 |
-
2016
- 2016-10-19 CN CN201610911768.3A patent/CN106631793B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1609086A (zh) * | 2003-04-14 | 2005-04-27 | 弗·哈夫曼-拉罗切有限公司 | Mptp亲和标记物 |
CN101223153A (zh) * | 2005-05-12 | 2008-07-16 | 默克勒有限公司 | 二苯并环庚烷化合物和含有这些化合物的药物 |
Non-Patent Citations (1)
Title |
---|
TAKASHI NISHIKATA ET AL.: "《An Efficient Generation of a Functionalized Tertiary-Alkyl Radical for Copper-catalyzed Tertiary-Alkylative Mizoroki-Heck type Reaction》", 《J. AM. CHEM. SOC.》 * |
Also Published As
Publication number | Publication date |
---|---|
CN106631793B (zh) | 2019-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108047107B (zh) | 二苯基二硒醚类化合物的制备方法 | |
CN111690947B (zh) | 三氟甲基化芳基酰胺衍生物的电化学合成方法 | |
CN112028809B (zh) | 一种3-胺基-4-苯硒基马来酰亚胺化合物的制备方法 | |
CN102702024A (zh) | 肟基脱氢枞酸化合物及其合成方法 | |
CN107188832A (zh) | 一种利用二氧化碳合成含三氟甲基的氨基甲酸酯的方法 | |
CN109761897B (zh) | 一种铜催化N-杂环芳烃类化合物C(sp2)-H键的烷基化的方法 | |
CN113416150A (zh) | 一种洛铂中间体的新合成方法 | |
CN106631793B (zh) | 一种二苯并环庚烷衍生物的制备方法 | |
CN104892350B (zh) | 一种含溴二氟甲基化合物及其制备方法 | |
US20080103316A1 (en) | Process for stereoselectively reducing 4-ARYL-4-oxobutanoic acid derivatives | |
Lin et al. | Synthesis of esters from aldehydes or carboxylic acids with dichloromethane, dichloroethane or dichloropropane under mild conditions | |
Itoh et al. | Synthesis of novel bis-and oligo-gem-difluorocyclopropanes | |
Tantrakarn et al. | Synthesis of redox-active biscalix [4] quinones and their electrochemical properties | |
CN109776409B (zh) | 一种利用微通道反应装置合成c-2位多氟官能基团取代喹啉的方法 | |
Zhang et al. | Methyltrioxorhenium-catalyzed epoxidation of olefins with hydrogen peroxide as an oxidant and pyridine N-oxide ionic liquids as additives | |
CN112126941B (zh) | 一种多取代10-羟基菲衍生物及其制备方法 | |
CN106810508B (zh) | 一种铁催化多组分反应合成苯并[1,4]-氧氮杂卓化合物的方法 | |
Wagh et al. | Allylation of 1-phenyl-1-propyne with N-and O-pronucleophiles using polymer supported triphenylphosphine palladium complex as a heterogeneous and recyclable catalyst | |
CN111138325B (zh) | 一种(Z)-β-磺酰基烯胺类化合物的制备方法 | |
CN116041220B (zh) | 一种芳基取代的酰胺类化合物的制备方法 | |
CN110407677B (zh) | 二苯乙二酮类化合物的制备方法及应用 | |
CN106699491A (zh) | 一种基于c‑h活化苯胺类叠氮化制备叠氮类化合物的方法 | |
CN113234061B (zh) | 一种双取代螺环芳烃的合成方法 | |
CN111484476B (zh) | 3氢-1,2-二硫代2,2-二氧化物及其制备方法 | |
Vardelle et al. | An efficient access to new Tröger’s bases using superacidic chemistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |